1. Severe B-cell-mediated CNS disease secondary to alemtuzumab therapy. Issue 2 (February 2017) Authors: Haghikia, Aiden; Dendrou, Calliope A; Schneider, Ruth; Grüter, Thomas; Postert, Thomas; Matzke, Mike; Stephanik, Heike; Fugger, Lars; Gold, Ralf Journal: Lancet neurology Issue: Volume 16:Issue 2(2017:Feb.) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗